Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Impact of Switching to Continuous Release Dopamine Agonists
This study has been completed.
Study NCT00465452 Information provided by University of Toledo Health Science Campus
First Received: April 24, 2007 Last Updated: March 18, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Parkinson Disease
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Additional drug interventions recognized in this trial
Dopamine
Dopamine Agents
Dopamine Agonists
More general drug interventions related to this trial
Autonomic Agents
Cardiotonic Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
University of Toledo Health Science Campus
Back to top of Main Content
